Indications and Purposes
| 1 Indications And Usage Skyrizi ® Is Indicated For The Treatment Of Moderate-To-Severe Plaque Psoriasis In Adults Who Are Candidates For Systemic Therapy Or Phototherapy. Skyrizi Is An Interleukin-23 Antagonist Indicated For The Treatment Of Moderate-To-Severe Plaque Psoriasis In Adults Who Are Candidates For Systemic Therapy Or Phototherapy. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Risankizumab-Rzaa |